The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma Journal Article


Authors: Oricchio, E.; Nanjangud, G.; Wolfe, A. L.; Schatz, J. H.; Mavrakis, K. J.; Jiang, M.; Liu, X.; Bruno, J.; Heguy, A.; Olshen, A. B.; Socci, N. D.; Teruya-Feldstein, J.; Weis-Garcia, F.; Tam, W.; Shaknovich, R.; Melnick, A.; Himanen, J. P.; Chaganti, R. S. K.; Wendel, H. G.
Article Title: The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma
Abstract: Insights into cancer genetics can lead to therapeutic opportunities. By cross-referencing chromosomal changes with an unbiased genetic screen we identify the ephrin receptor A7 (EPHA7) as a tumor suppressor in follicular lymphoma (FL). EPHA7 is a target of 6q deletions and inactivated in 72% of FLs. Knockdown of EPHA7 drives lymphoma development in a murine FL model. In analogy to its physiological function in brain development, a soluble splice variant of EPHA7 (EPHA7TR) interferes with another Eph-receptor and blocks oncogenic signals in lymphoma cells. Consistent with this drug-like activity, administration of the purified EPHA7TR protein produces antitumor effects against xenografted human lymphomas. Further, by fusing EPHA7 TR to the anti-CD20 antibody (rituximab) we can directly target this tumor suppressor to lymphomas in vivo. Our study attests to the power of combining descriptive tumor genomics with functional screens and reveals EPHA7TR as tumor suppressor with immediate therapeutic potential. © 2011 Elsevier Inc.
Keywords: controlled study; human tissue; nonhuman; rituximab; animal cell; mouse; animals; mice; animal experiment; animal model; rna interference; in vivo study; cell line, tumor; disease model; protein purification; murinae; transplantation, heterologous; genomics; chromosomes, human, pair 6; neoplasm transplantation; protein variant; follicular lymphoma; lymphoma, follicular; genes, tumor suppressor; antibodies, monoclonal, murine-derived; ephrin receptor a7; receptor, epha7
Journal Title: Cell
Volume: 147
Issue: 3
ISSN: 0092-8674
Publisher: Cell Press  
Date Published: 2011-10-28
Start Page: 554
End Page: 564
Language: English
DOI: 10.1016/j.cell.2011.09.035
PROVIDER: scopus
PMCID: PMC3208379
PUBMED: 22036564
DOI/URL:
Notes: --- - "Cited By (since 1996): 1" - "Export Date: 9 December 2011" - "CODEN: CELLB" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Adriana Heguy
    88 Heguy
  2. Julie T Feldstein
    298 Feldstein
  3. Adam B Olshen
    107 Olshen
  4. Juha P Himanen
    50 Himanen
  5. Nicholas D Socci
    266 Socci
  6. Hans Guido Wendel
    102 Wendel
  7. Raju S K Chaganti
    391 Chaganti
  8. Jonathan Harry Schatz
    15 Schatz
  9. Man Jiang
    20 Jiang
  10. Andrew Lerner Wolfe
    12 Wolfe
  11. Xiaoping Liu
    6 Liu